Company Description
VG Life Sciences (OTC Link: VGLS) is a publicly traded shell companies company in the Financial Services sector. The company has a market capitalization of $232.3K.
VGLS stock has declined 89.0% over the past year. Shares last traded at $0.2202.
On a trailing twelve-month basis, VG Life Sciences reported revenue of $0 with net income of -$6.2M.
This page provides a comprehensive overview of VGLS stock, including price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
VG Life Sciences (VGLS) stock last traded at $0.2202. Over the past 12 months, the stock has lost 89.0%. At a market capitalization of $232.3K, VGLS is classified as a micro-cap stock with approximately 1.1M shares outstanding.
Latest News
SEC Filings
VG Life Sciences has filed 2 recent SEC filings, including 1 Form RW, 1 Form 10-12G. The most recent filing was submitted on May 5, 2026. SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all VGLS SEC filings →
Financial Highlights
operating income reached -$4.1M, and net income was -$6.2M. The company generated -$1.9M in operating cash flow. With a current ratio of 0.04, short-term liquidity bears monitoring.
Upcoming Events
Short Interest History
Days to Cover History
VGLS Company Profile & Sector Positioning
VG Life Sciences (VGLS) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the OTC Link.